ISRCTN33950739已完成不适用
Assessment of the humoral immune response and safety of reduced doses of influenza vaccine administered intradermally compared to intramuscular administratio
Berna Biotech AG, Crucell Company (Switzerland)0 个研究点目标入组 275 人开始时间: 2007年11月14日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 275
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Healthy volunteers between 18 and 60 years of age.
排除标准
- •1. Pregnancy and lactation
- •2. Treatment with immunoglobulins or blood transfusions
- •3. Immunodeficiency
- •4. History of egg protein allergy/severe atopy/serious adverse reaction to influenza vaccine
- •5. Previous vaccination against influenza in the past 330 days
- •6. Participation in another clinical trial
- •7. Known blood coagulation disorders
- •8. Acute febrile illness
研究者
相似试验
已完成
不适用
Evaluation of humoral immune response induced by a supplemental dose of inactivated poliovirus vaccine (IPV) administered intradermally or intramuscularly versus a dose of monovalent type 1 oral poliovirus vaccineISRCTN90744784Panacea Biotec Limited (India)1,000
招募中
4 期
Immunologic response to hepatitis B immunization in children post liver transplantatioSafety and efficacy of hepatitis B vaccine, standard compare to double dose in short and long term follow-up.infection, bleeding, painTCTR20180723002Chulalonkorn University72
招募中
不适用
CIMAvax-EGF in different maintenance schemeson small cell lung cancerCarcinoma, Non-Small-Cell LungCarcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesNSCLCRPCEC00000368Center of Molecular Immunology (CIM)42
招募中
2 期
Preliminary study: Safety and Immunological Response following COVID-19 Vaccination in COVID-19 survivorsCOVID-19 survivorsCOVID-19 VaccinationTCTR20210720005Faculty of Medicine Siriraj Hospital180
已完成
不适用
Assessment of the immunogenicity and safety of the Northern Hemisphere 2010/2011-season influenza vaccine in elderly and young subjects according to European Medicines Agency (EMEA) regulationsInfluenzaISRCTN89337058Crucell Switzerland AG (Switzerland)110